Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.

Simple item page
dc.contributor.authorOkwera, Alphonse
dc.contributor.authorMafigiri, David K.
dc.contributor.authorGuwatudde, David
dc.contributor.authorWhalen, Christopher
dc.contributor.authorJoloba, Moses
dc.date.accessioned2022-04-29T19:24:00Z
dc.date.available2022-04-29T19:24:00Z
dc.date.issued2015
dc.description.abstractCo-trimoxazole use is the standard of care for preventing Pneumocystis jirovecii pneumonia in sub-Saharan Africa but implementation remains slow. Co-trimoxazole is self- administered with uncertain adherence. Knowledge of co-trimoxazole use among HIV infected persons is unknown. Objectives: To assess knowledge, attitudes and practices of co-trimoxazole use among HIV infected adults evaluated for recurrent PTB in Kampala, Uganda. Methods: A qualitative study utilizing 5 focus group discussions among 30 HIV infected PTB suspects at the national referral tuberculosis treatment centre in Kampala. Results: Males and females had similar median ages. 80% were currently on co-trimoxazole and 50% of participants were on HAART. Majority of participants defined co-trimoxazole as an analgesic. Few noted co-trimoxazole was a drug to treat cough and chest pain. However, few responses revealed that co-trimoxazole prevents opportunistic diseases among PLHIV. Most of participants believed HAART and anti-TB drugs work as co-trimoxazole thus it should not be taken together with them. This belief may lead to increased risk of opportunistic infections, morbidity and mortality. Conclusions: We revealed gaps in understanding of co-trimoxazole use among study participants. We therefore recommend that more facts about co-trimoxazle as prophylaxis against P. jirovecii, bacterial and diarrheal pathogens should be incorporated in VCT fact sheets.en_US
dc.identifier.citationOkwera, A., Mafigiri, D. K., Guwatudde, D., Whalen, C., & Joloba, M. (2015). Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis. African Health Sciences, 15(1), 49-57. http://dx.doi.org/10.4314/ahs.v15i1.7en_US
dc.identifier.urihttp://dx.doi.org/10.4314/ahs.v15i1.7
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/3009
dc.language.isoenen_US
dc.publisherAfrican Health Sciencesen_US
dc.subjectRecurrent tuberculosisen_US
dc.subjectHIVen_US
dc.subjectCo-trimoxazole useen_US
dc.subjectChemoprophylaxisen_US
dc.subjectAdherenceen_US
dc.titleLevel of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary.pdf
Size:
208.68 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences